DN 1 - 2 - 2026
Senaste Nr DiabetologNytt i PDF
Arkiv alla nyheter

Richard Dennis Di Marchi and Matthias Tschoep awarded the Rolf Luft Award 2026. Program Award Ceremony 10/9 2026

Rolf Luft Award Ceremony (KI) and Rolf Luft Symposium 10 Sept 2026

 

Richard Dennis Di Marchi, Indiana University, Bloomington, USA and Matthias Tschoep, Ludvig Maximillian University, Munich, Germany

are awarded the Rolf Luft Award 2026 for outstanding, groundbreaking scientific contribution in diabetes and obesity

with basic research leading to important clinical implications with the Short motivation;

”for advances in peptide chemistry and the development of novel dual and triple agonists for the treatment of diabetes and obesity”

 

 

Extended motivation

Professors Richard DiMarchi and Matthias Tschöp discovered a new class of drugs with unprecedented efficacy in treating diabetes and obesity. Several versions of these so-called gut hormone poly-agonists have advanced through clinical trials. One class representative, with the same active peptide ingredient named tirzepatide advanced by Eli Lilly, has already been FDA approved for treating type 2 diabetes in 2022 as “Mounjaro” and obesity in 2023 as “Zepbound.”

 

Treatment of obese patients with tirzepatide decreased patients’ body weight more than 20%, an excess weight where obesity is typically defined. This level of weight lowering had previously only been possible with gastric bypass surgery. The discovery and validation of these highly efficient drugs for obesity, by DiMarchi & Tschöp have accomplished a transformative breakthrough, which provides a path for reversing the obesity pandemic. Additionally, it has set a direction in drug discovery for complex diseases when there is no effective therapy and more than one integrated mechanism in action might prove equally effective as demonstrated in obesity.

 

 

PROGRAM (preliminär) Seot 10 2026

Rolf Luft Award Ceremony (KI)

13:00 Introduction, Chair Kerstin Brismar, KI

13:05 Rolf Luft Award Ceremony

President or Vice-President for Research, Karolinska Institutet TBD

Recipient of Rolf Luft Award: Richard Dennis Di Marchi, Indiana University, Bloomington, USA and Matthias Tschoep, Ludvig Maximillian University, Munich, Germany

 

13:10 The Prize lectures: Professors Richard Dennis Di Marchi and Matthias Tschoep   , title TBD

 

14:15                  Short interval

 

Rolf Luft Symposium

 

14:20                 Rolf Luft Symposium

Chair Daniel Andersson, KI

14:25                 Hannes docent, fettlever en diabeteskomplikation

14:45                  Sergiu  docent/lektor MIR 210 och diabeteskomplikationer

 

15.00                      Coffe/tea interval  fruktpaus)

 

 

Call for grant applications:

Kerstin Brismar Award 2026

 

FOR THE BEST PROGRAM FOR

TRANSLATIONAL RESEARCH

THE AWARDEE WILL RECEIVE A DIPLOMA AND A

GRANT OF SEK 500.000 FOR TRANSLATIONAL

RESEARCH.

 

 

THE PRIZE CEREMONY WILL TAKE PLACE AT

KAROLINSKA INSTITUTET, STOCKHOLM, FOLLOWED

BY A LECTURE ON HIS/HER RESEARCH TO AN

AUDIENCE OF BASIC AND CLINICAL RESEARCHERS

AND CLINICIANS. THE SETTINGS WILL BE A HALF

DAY SYMPOSIUM

ACCEPTING APPLICATIONS THROUGH

MAY 2026

 

 

The application should in one single PDF file include: a letter of intention with a short

description of the project (max one page), a short CV (max one page), a list of the

applicant´s ten most important publications and a research program with a budget and

a description of the contribution of the research to science and health (no more than

five pages). In addition, a CV with a complete list of all publications should be sent as a

separate PDF file.

The application should be submitted electronically to:

Brismaraward@luftdiabetesfoundation.se

 

 

2027 ROLF LUFT AWARD

FOR EXCEPTIONAL CONTRIBUTIONS TO DIABETES, ENDOCRINOLOGY AND METABOLISM

• THE PRIZE CEREMONY WILL TAKE PLACE AT NOBEL FORUM, KAROLINSKA INSTITUTET

AT THE CEREMONY THE AWARDEE WILL RECEIVE THE ROLF LUFT MEDAL, A DIPLOMA AND HONORARIUM

AND GIVE A PRIZE LECTURE ON HIS/HER RESEARCH TO AN AUDIENCE OF BASIC AND CLINICAL RESEARCHERS AND CLINICIANS.

THE SETTING WILL BE A HALF DAY SYMPOSIUM

 

ACCEPTING NOMINATIONS THROUGH SEPTEMBER 30, 2026

The nomination should, in one single PDF file include: a short CV (max five pages without ref.), a list of the nominee’s ten most important

publications and a short description of the nominee’s contributions to science and health (no more than one page or 500 words).

In addition, a CV with a complete list of all publications should be sent as a separate PDF file.

Nominations should be submitted as a single file by email to: luftaward@rolfluftdiabetesfond.se

 

Inskickat till www red av Kerstin Brismar

 

 

Nyhetsinfo

www red DiabetologNytt

Facebook
LinkedIn
Email
WhatsApp